Cabot (NYSE:CBT) Issues FY25 Earnings Guidance
by Renee Jackson · The Cerbat GemCabot (NYSE:CBT – Get Free Report) updated its FY25 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $7.40-7.80 for the period, compared to the consensus estimate of $7.85. Cabot also updated its FY 2025 guidance to 7.400-7.800 EPS.
Cabot Stock Down 1.8 %
Shares of CBT traded down $1.93 during trading on Tuesday, reaching $108.16. The company’s stock had a trading volume of 365,728 shares, compared to its average volume of 336,202. Cabot has a twelve month low of $66.02 and a twelve month high of $117.14. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. The company has a market cap of $5.93 billion, a price-to-earnings ratio of 12.87, a P/E/G ratio of 0.91 and a beta of 1.20. The company has a fifty day moving average of $108.30 and a two-hundred day moving average of $101.01.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.65 earnings per share. On average, sell-side analysts predict that Cabot will post 7.07 EPS for the current fiscal year.
Wall Street Analyst Weigh In
CBT has been the subject of several research analyst reports. Mizuho boosted their price objective on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a report on Tuesday. UBS Group dropped their target price on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $105.00.
Check Out Our Latest Stock Analysis on CBT
Insider Transactions at Cabot
In other news, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the sale, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, CFO Erica Mclaughlin sold 16,390 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares of the company’s stock, valued at $6,235,011.36. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares in the company, valued at approximately $33,630,719.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 71,939 shares of company stock valued at $7,308,812. Corporate insiders own 3.07% of the company’s stock.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
- Five stocks we like better than Cabot
- Dividend Capture Strategy: What You Need to Know
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Why is the Ex-Dividend Date Significant to Investors?
- Insider Buying Signals Upside for These 3 Stocks
- Where to Find Earnings Call Transcripts
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink